Leptin upregulates COX‑2 and its downstream products in aortic endothelial cells

Chen,Yuelin; Shen,Yuechun; Nie,Ya; Chen,Zhongxin; Wang,Huang; Liao,Huang; Li,Jun

doi:10.3892/etm.2017.5177

Leptin upregulates COX‑2 and its downstream products in aortic endothelial cells

Authors:
- Yuelin Chen
- Yuechun Shen
- Ya Nie
- Zhongxin Chen
- Huang Wang
- Huang Liao
- Jun Li
View Affiliations

Affiliations: Department of Cardiology, Affiliated Zhongshan Hospital of Guangdong Medical University, Zhongshan, Guangdong 528415, P.R. China, Department of Cardiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China, Department of General Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China
Published online on: September 21, 2017 https://doi.org/10.3892/etm.2017.5177
Pages: 5097-5102

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The adipocyte‑derived hormone leptin is associated with hypertension. The involvement of cyclooxygenase‑2 (COX‑2) and its downstream vasomotor products prostaglandin (PG) and thromboxane (TX)A2 in the mechanisms of action of leptin have remained elusive. The aim of the present study was to investigate the effects of leptin on the expression of COX‑2 by rat aortic endothelial cells (RAECs) and the concentration of its products, represented by 6‑keto PGF1α and TXB2, in the culture media. RAECs were isolated, cultured and identified by immunofluorescence staining. The RAECs were incubated with different concentrations of leptin (10‑10, 10‑9 and 10‑8 M) for various durations (36 or 48 h). COX‑2 mRNA and protein expression in the cells was detected by reverse‑transcription quantitative PCR and western blot analysis, respectively. The vasodilator 6‑keto PGF1α and the vasoconstrictor TXB2 were detected in the supernatant by ELISA. The cultured cells displayed specific factor VIII expression in the cytoplasm. Compared with the PBS‑treated control group, leptin significantly increased the expression of COX‑2 mRNA and protein in a time‑ and dose‑dependent manner (P<0.01). Furthermore, the vasodilator 6‑keto PGF1α was increased and the TXB2/6‑keto PGF1α ratio decreased only with relatively high concentrations of leptin (10‑9 or 10‑8 M; P<0.01), but TXB2 levels were not affected (P>0.05). In conclusion, leptin significantly increased the expression of inflammatory marker COX‑2 and its downstream product 6‑keto PGF1α, while also decreasing the TXB2/6‑keto PGF1α ratio in vitro. These observations suggested that COX‑2 may have an important role in the effects of leptin on inflammation, such as the low‑inflammatory disease hypertension. However, selective COX‑2 inhibitors may increase the risk of hypertension due to inhibiting 6‑keto PGF1α, the vasodilator product of COX‑2.

View Figures

View References

1	Münzberg H and Morrison CD: Structure, production and signaling of leptin. Metabolism. 64:13–23. 2015. View Article : Google Scholar : PubMed/NCBI
2	Wada N, Hirako S, Takenoya F, Kageyama H, Okabe M and Shioda S: Leptin and its receptors. J Chem Neuroanat. 61-62:1–199. 2014. View Article : Google Scholar : PubMed/NCBI
3	Kang YS: Obesity associated hypertension: New insights into mechanism. Electrolyte Blood Press. 11:46–52. 2013. View Article : Google Scholar : PubMed/NCBI
4	Artwohl M, Roden M, Hölzenbein T, Freudenthaler A, Waldhäusl W and Baumgartner-Parzer SM: Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord. 26:577–580. 2002. View Article : Google Scholar : PubMed/NCBI
5	Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS and Somers VK: Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 27:e302–e307. 2007. View Article : Google Scholar : PubMed/NCBI
6	Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, Muellner C, Speiser W and Wagner O: Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 90:711–718. 2002. View Article : Google Scholar : PubMed/NCBI
7	Benkhoff S, Loot AE, Pierson I, Sturza A, Kohlstedt K, Fleming I, Shimokawa H, Grisk O, Brandes RP and Schröder K: Leptin potentiates endothelium-dependent relaxation by inducing endothelial expression of neuronal NO synthase. Arterioscler Thromb Vasc Biol. 32:1605–1612. 2012. View Article : Google Scholar : PubMed/NCBI
8	Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, d'Amati G and Trimarco B: Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes. 49:293–297. 2000. View Article : Google Scholar : PubMed/NCBI
9	Santovito D, Mezzetti A and Cipollone F: Cyclooxygenase and prostaglandin synthases: Roles in plaque stability and instability in humans. Curr Opin Lipidol. 20:402–408. 2009. View Article : Google Scholar : PubMed/NCBI
10	Kobayashi M, Inoue K, Warabi E, Minami T and Kodama T: A simple method of isolating mouse aortic endothelial cells. J Atheroscler Thromb. 12:138–142. 2005. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Shek EW, Brands MW and Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension. 31:409–414. 1998. View Article : Google Scholar : PubMed/NCBI
13	Beltowski J: Leptin and the regulation of renal sodium handling and renal na-transporting ATPases: Role in the pathogenesis of arterial hypertension. Curr Cardiol Rev. 6:31–40. 2010. View Article : Google Scholar : PubMed/NCBI
14	Wojcicka G, Jamroz-Wiśniewska A, Widomska S, Ksiazek M and Bełtowski J: Role of extracellular signal-regulated kinases (ERK) in leptin-induced hypertension. Life Sci. 82:402–412. 2008. View Article : Google Scholar : PubMed/NCBI
15	Durand MJ and Gutterman DD: Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation. 20:239–247. 2013. View Article : Google Scholar : PubMed/NCBI
16	Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Trimarco B and Lembo G: Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 51:168–173. 2002. View Article : Google Scholar : PubMed/NCBI
17	Manuel-Apolinar L, Lopez-Romero R, Zarate A, Damasio L, Ruiz M, Castillo-Hernández C, Guevara G and Mera-Jiménez E: Leptin mediated ObRb receptor increases expression of adhesion intercellular molecules and cyclooxygenase 2 on murine aorta tissue inducing endothelial dysfunction. Int J Clin Exp Med. 6:192–196. 2013.PubMed/NCBI
18	Garonna E, Botham KM, Birdsey GM, Randi AM, Gonzalez-Perez RR and Wheeler-Jones CP: Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells. PLoS One. 6:e188232011. View Article : Google Scholar : PubMed/NCBI
19	Rahme E, Pilote L and Lelorier J: Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med. 162:1111–1115. 2002. View Article : Google Scholar : PubMed/NCBI
20	De Vecchis R, Baldi C, Di Biase G, Ariano C, Cioppa C, Giasi A, Valente L and Cantatrione S: Cardiovascular risk associated with celecoxib or etoricoxib: A meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen. Minerva Cardioangiol. 62:437–448. 2014.PubMed/NCBI
21	Mcgettigan P and Henry D: Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 8:e10010982011. View Article : Google Scholar : PubMed/NCBI